Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.

Abstract

The current recommended infant vaccination schedules require many injections at multiple sites, which increase stress for infants and parents and may create challenges to vaccination compliance. Therefore, combination vaccines, which reduce the number of injections at each medical visit, can be an essential method to improve compliance. The objective of… (More)
DOI: 10.1016/j.vaccine.2010.11.053

Topics

Cite this paper

@article{DiazMitoma2011SafetyAI, title={Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.}, author={Francisco Diaz-Mitoma and Scott Alan Halperin and Bruce F Tapi{\'e}ro and Agn{\`e}s Hoffenbach and Pamela S Zappacosta and David R Radley and Susan K Bradshaw and J A Carneros Mart{\'i}n and John W Boslego and Teresa M. Hesley and Prakash K Bhuyan and Jeffrey L Silber}, journal={Vaccine}, year={2011}, volume={29 6}, pages={1324-31} }